Coronavirus disease 2019 (COVID‐19) is a new infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that belongs to the coronavirus family …

During the COVID-19 pandemic, high consumption of antivirals, antibiotics, antiparasitics,
antiprotozoals, and glucocorticoids used in the treatment of this virus has been reported …

Background: Coronavirus Disease 2019 (COVID-19) became the deadliest pandemic of the
new millennium. One year after it became a pandemic, the current COVID-19 situation in …

In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the …

Abstract Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is closely related to two other …

Objectives To evaluate risk factors associated with unfavourable outcomes: emergency care,
hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death in …

Much more serious than the previous severe acute respiratory syndrome (SARS)
coronavirus (CoV) outbreaks, the novel SARS-CoV-2 infection has spread speedily …

The ongoing pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has drawn the attention of researchers and clinicians from several disciplines …

(Background) Lopinavir-ritonavir (LPV/RTV) is a human immunodeficiency virus (HIV)
antiviral combination that has been considered for the treatment of COVID-19 disease.(Aim) …

Background The global push for the use of hydroxychloroquine (HCQ) and chloroquine (CQ)
against COVID-19 has resulted in an ongoing discussion about the effectivity and toxicity of …